Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » Patient

Patient

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 10/07/19 by Áine Maguire

An audit on waste of adult systemic anticancer therapy at University College London Hospitals NHS Foundation Trust Pharmacy Aseptic Production Unit

Abstracts

View resources
Last reviewed: 17/03/21 by Kristen Moorhouse

Implementation of Guidelines for the Management of Immune-related Adverse Reactions of Immuno-Oncology Agents.

Abstracts

View resources
Last reviewed: 10/07/19 by Julie Clarke

New treatments for advanced (unresectable or metastatic) melanoma: what do they mean for patients? Real world experience from NHS Greater Glasgow and Clyde

Abstracts

View resources
Last reviewed: 10/07/19 by Stephanie Lister

The Stability of Plerixafor (Mozobil) in pre-filled syringes for patient administration in an ambulatory setting.

Abstracts

View resources
Last reviewed: 10/07/19 by Nina Paton

Pharmacists role in promoting and supporting the use a health care app in an oncology setting

Abstracts

View resources
Last reviewed: 10/07/19 by Nick Duncan

Adverse event and efficacy monitoring in patients receiving oral tyrosine kinase inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)

Abstracts

View resources
Last reviewed: 17/03/21 by Darren Walsh

Audit of Year One: Post Implementation of National Intrathecal Chemotherapy (ITC) Policy

Abstracts

View resources
Last reviewed: 10/07/19 by Alice Tew

Development of a Dose Banding Table for Oral Temozolomide

Abstracts

View resources
Last reviewed: 10/07/19 by Nicola Stoner

A patient satisfaction survey of a new cancer satellite pharmacy

Abstracts

View resources
Last reviewed: 10/07/19 by Hector Mateo-Carrasco

Safety of extended temozolomide regimes in brain tumour patients

Abstracts

View resources
Last reviewed: 10/07/19 by Debra LN Robertson

A focus group to explore the experiences and opinions of generalist pharmacy staff providing pharmaceutical care to patients with cancer on non-cancer wards

Abstracts

View resources
Last reviewed: 10/07/19 by Róisín O'Donohgue

Immune checkpoint inhibitors – A multi-disciplinary aprroach to improve practice and patient safety

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 2 3 4 5 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.